Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

CompletedOBSERVATIONAL
Enrollment

890

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

February 28, 2013

Conditions
Acute Kidney Injury
Trial Locations (35)

1090

UZ Brussel, Brussel

6020

University Clinic for Internal Medicine, Innsbruck

9000

Ghent University Hospital, Ghent

10467

Montefiore Medical Center, The Bronx

11215

New York Methodist Hospital, Brooklyn

15261

University of Pittsburgh Medical Center, Pittsburgh

17176

Karolinska University Hospital, Solna

19104

Hospital of the University of Pennsylvania, Philadelphia

20037

George Washington University, Washington D.C.

21201

University of Maryland Medical Center, Baltimore

23298

Virginia Commonwealth University, Richmond

27705

Durham VA Medical Center, Durham

30909

Joseph M. Still Research Foundation, Inc., Augusta

33125

Bruce W. Carter Department of Veterans Affairs Medical Center, Miami

33600

Haut-Lévéque Hospital, Pessac

33606

Tampa General Hospital, Tampa

39120

Otto-von-Guericke-Universitat Magdeburg, Madgeburg

40202

University of Louisville, Louisville

48374

Providence Park Hospital, Novi

52074

Universitätsklinikum Aachen, Aachen

55905

Mayo Clinic, Rochester

60590

Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Frankfurt

Universitätsklinik Frankfurt am Main, Frankfurt

60637

University of Chicago Medical Center Section of Nephrology, Chicago

69003

Edouard Herriot Hospital, Lyon

77000

Marc Jacquet Hospital, Melun

85008

Maricopa Intergrated Health System, Phoenix

92103-8781

University of California San Diego, San Diego

32610-0254

University of Florida, Gainesville

02215

Beth Israel Deaconess Med. Center (BIDMC), Boston

T6G 2B7

University of Alberta, Edmonton

08208

Critical Care Center, Sabadell Hospital, Sabadell

SE1 7EH

Guy's and St. Thomas Hospital, London

SE5 9RS

King's College Hospital, London

BN11 2DH

Worthing Hospital, Worthing

Sponsors
All Listed Sponsors
lead

Astute Medical, Inc.

INDUSTRY

NCT01209169 - Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury | Biotech Hunter | Biotech Hunter